Table 1.
Sociodemographic, clinical, and general characteristics of the pneumonic process caused by COVID-19 in the patients included in the study.
| Variables | Total N = 200 |
|---|---|
| Demographics and Clinics before Admission | |
| Male sex, N (%), | 119 (59.5) |
| Age, years | 62 (50–71) |
| Body mass index (Kg/m2) | 28.7 (25.9–31.9) |
| Previous and current smoker, N (%) | 84 (42) |
| History of chronic cardiopathy, N (%) * | 37 (18.5) |
| History of diabetes, N (%) | 23 (11.5) |
| History of hypertension, N (%) | 74 (37) |
| History of COPD, N (%) | 6 (3) |
| History of chronic renal failure, N (%) | 7 (3.5) |
| ECOG score | 1 (1–2) |
| ECOG score ≥ 2, N (%) | 51 (25.5) |
| In Relation to the Pneumonic Process | |
| Bilateral radiographic involvement, N (%) | 139 (69.5) |
| Oxygen saturation at hospital admission | 96 (94–98) |
| Pneumonia Severity Index | 61 (49–75) |
| Pneumonia Severity Index ≥ 3, N (%) | 62 (31) |
| Need non-invasive ventilatory support, N (%) | 12 (6) |
| ICU admission, N (%) | 31 (15.5) |
| Lowest level of lymphocites (109/L) | 0.75 (0.55–1.04) |
| Maximum level of C-reactive protein (mg/L) | 83.3 (31–160.1) |
| Maximum level of LDH (U/L) | 295 (227.7–386.7) |
| Maximum level of D-dimer (ng/mL) ** | 1150.1 (476.2–2856) |
| Length of stay (days) | 7 (4–13) |
* History of ischaemic heart disease or chronic heart failure; ** Available in 94 patients only; COPD: Chronic obstructive pulmonary disease; ECOG: Eastern Cooperative Oncology Group; ICU: Intensive care unit.